Literature DB >> 9723244

Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.

A Foradori1, S Mezzano, C Videla, J Pefaur, A Elberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723244     DOI： 10.1016/s0041-1345(98)00393-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  12 in total

1.  Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.

Authors:  Yong Song; Wujun Xue; Puxun Tian; Xiaoming Ding; Xiaoming Pan; Hang Yan; Jun Hou; Xinshun Feng; Heli Xiang; Xiaohui Tian; Gaoping Qin; Xiaohu Fan
Journal:  Eur J Clin Pharmacol       Date:  2011-01-29       Impact factor: 2.953

Review 2.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 3.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

Review 4.  [Drug-drug interactions in urology].

Authors:  M C Michel; R F Schäfers; J J M C H de la Rosette
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

5.  Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful.

Authors:  Fernando González; Ricardo Valjalo
Journal:  World J Transplant       Date:  2015-12-24

6.  Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies.

Authors:  Espen Molden; Beate Hennie Garcia; Pia Braathen; Anne Elise Eggen
Journal:  Eur J Clin Pharmacol       Date:  2005-02-04       Impact factor: 2.953

7.  The use of a cyclosporin-ketoconazole combination: making renal transplantation affordable in developing countries.

Authors:  T Gerntholtz; M D Pascoe; J F Botha; J Halkett; D Kahn
Journal:  Eur J Clin Pharmacol       Date:  2004-04-09       Impact factor: 2.953

8.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

9.  General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.

Authors:  Yoshiyuki Ohno; Akihiro Hisaka; Hiroshi Suzuki
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

10.  A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.

Authors:  Akihiro Hisaka; Makiko Kusama; Yoshiyuki Ohno; Yuichi Sugiyama; Hiroshi Suzuki
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.